Hindustan Organic Chemicals Ltd
Incorporated in 1960, Hindustan Organic Chemicals Ltd is in the business of bulk industrial chemicals and chemical intermediates[1]
- Market Cap ₹ 248 Cr.
- Current Price ₹ 36.9
- High / Low ₹ 46.6 / 21.0
- Stock P/E
- Book Value ₹ 163
- Dividend Yield 0.00 %
- ROCE -0.02 %
- ROE -1.79 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.23 times its book value
- Company's median sales growth is 21.5% of last 10 years
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.28% over past five years.
- Company has a low return on equity of -11.4% over last 3 years.
- Contingent liabilities of Rs.99.4 Cr.
- Earnings include an other income of Rs.18.0 Cr.
- Working capital days have increased from 307 days to 505 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE CPSE
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 149 | 108 | 142 | 239 | 464 | 294 | 404 | 434 | 631 | 704 | 536 | 574 | 506 | |
| 272 | 222 | 302 | 428 | 441 | 353 | 353 | 425 | 625 | 705 | 622 | 591 | 505 | |
| Operating Profit | -123 | -115 | -160 | -190 | 23 | -59 | 51 | 9 | 6 | -1 | -86 | -18 | 1 |
| OPM % | -83% | -106% | -112% | -80% | 5% | -20% | 13% | 2.1% | 1.0% | -0.1% | -16% | -3.1% | 0.1% |
| -33 | 15 | 6 | 66 | 115 | 22 | 20 | 31 | 12 | 17 | 526 | 26 | 18 | |
| Interest | 51 | 66 | 95 | 75 | 66 | 56 | 53 | 66 | 67 | 70 | 43 | 20 | 20 |
| Depreciation | 9 | 9 | 7 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | -215 | -174 | -256 | -203 | 71 | -95 | 16 | -26 | -50 | -55 | 395 | -14 | -4 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | -7% | |
| -215 | -174 | -256 | -203 | 71 | -95 | 16 | -26 | -50 | -55 | 392 | -13 | -3 | |
| EPS in Rs | -32.08 | -25.89 | -38.05 | -30.29 | 10.55 | -14.11 | 2.38 | -3.90 | -7.48 | -8.24 | 58.29 | -1.92 | -0.40 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 7% |
| 3 Years: | -3% |
| TTM: | -21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | % |
| 3 Years: | 17% |
| TTM: | 97% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -2% |
| 3 Years: | 6% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -15% |
| 3 Years: | -11% |
| Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -871 | -1,048 | 80 | -20 | 59 | -38 | -7 | -17 | -60 | -56 | 1,038 | 1,029 |
| 672 | 682 | 596 | 602 | 602 | 516 | 429 | 1,127 | 1,186 | 1,262 | 115 | 194 | |
| 428 | 543 | 1,065 | 981 | 793 | 798 | 908 | 281 | 272 | 299 | 336 | 258 | |
| Total Liabilities | 296 | 243 | 1,807 | 1,631 | 1,521 | 1,342 | 1,397 | 1,458 | 1,465 | 1,572 | 1,555 | 1,548 |
| 117 | 101 | 1,637 | 102 | 120 | 126 | 136 | 155 | 165 | 226 | 227 | 231 | |
| CWIP | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Investments | 9 | 9 | 9 | 11 | 11 | 3 | 8 | 11 | 10 | 18 | 14 | 24 |
| 160 | 129 | 158 | 1,518 | 1,390 | 1,213 | 1,253 | 1,293 | 1,290 | 1,328 | 1,310 | 1,292 | |
| Total Assets | 296 | 243 | 1,807 | 1,631 | 1,521 | 1,342 | 1,397 | 1,458 | 1,465 | 1,572 | 1,555 | 1,548 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -113 | 47 | 64 | -342 | -157 | -82 | 18 | 12 | -13 | -66 | 631 | -70 | |
| 5 | -1 | 1 | 343 | 112 | 164 | 7 | 9 | 7 | 56 | 10 | 12 | |
| 85 | -46 | -63 | 71 | -0 | -90 | -16 | -33 | -10 | 6 | -642 | 58 | |
| Net Cash Flow | -23 | 0 | 1 | 73 | -45 | -8 | 9 | -13 | -16 | -4 | -1 | -0 |
| Free Cash Flow | -109 | 45 | 64 | 0 | -49 | 74 | 18 | 11 | -14 | -67 | 624 | -72 |
| CFO/OP | 92% | -41% | -40% | 180% | -668% | 139% | 35% | 128% | -203% | 6,570% | -733% | 401% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 22 | 13 | 7 | 14 | 10 | 2 | 6 | 10 | 10 | 10 | 5 |
| Inventory Days | 222 | 263 | 368 | 180 | 70 | 94 | 99 | 109 | 44 | 53 | 52 | 44 |
| Days Payable | 444 | 972 | 1,179 | 520 | 135 | 67 | 30 | 57 | 34 | 50 | 42 | 14 |
| Cash Conversion Cycle | -168 | -687 | -798 | -333 | -51 | 37 | 72 | 58 | 21 | 12 | 20 | 35 |
| Working Capital Days | -786 | -1,579 | -3,255 | 473 | 306 | 171 | 32 | -50 | -93 | -142 | 558 | 505 |
| ROCE % | -72% | -19% | 15% | -6% | 13% | 5% | 1% | 1% | -5% | -0% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Acetone Production MT |
|
|||||||||
| Hydrogen Peroxide Production MT |
||||||||||
| Phenol Production MT |
||||||||||
| Phenol Plant Capacity Utilization % |
||||||||||
| Hydrogen Peroxide Plant Capacity Utilization % |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- CAG reappointed M/s. Balan & Co as HOCL statutory auditor for FY 2026-27.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Ad w.r.t AGM Notice is hereby submitted
-
AGM Notice
- 65th AGM on 25 September 2026 at 3:30 p.m. via VC/OAVM.
- Reg. 34 (1) Annual Report.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Ad informing AGM is submitted
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
HOCL was set up as a Government of India enterprise (government holds ~ 58.78% equity stake) under the administrative control of Ministry of Chemicals and Fertilizers. It is the 2nd largest producer of Phenol and Acetone
in India. Company manufactures Hydrogen Peroxide. The raw materials used by HOCL are Benzene and LPG, which come from petroleum refineries. Currently, 500+ units based on HOC’s products are setup across India. It also produces versatile engineering plastic polytetrafluoroethylene (PTFE) through its subsidiary viz. Hindustan Flurocarbons Limited (HFL)